See more : Oryzon Genomics S.A. (ORYZF) Income Statement Analysis – Financial Results
Complete financial analysis of KOSÉ Corporation (4922.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of KOSÉ Corporation, a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- 1399 Internet Technology Application Group Inc. (YSGG) Income Statement Analysis – Financial Results
- América Móvil, S.A.B. de C.V. (AMXB.MX) Income Statement Analysis – Financial Results
- Ta Chen Stainless Pipe Co., Ltd. (2027.TW) Income Statement Analysis – Financial Results
- GreenSky, Inc. (GSKY) Income Statement Analysis – Financial Results
- Catalent, Inc. (CTLT) Income Statement Analysis – Financial Results
KOSÉ Corporation (4922.T)
About KOSÉ Corporation
KOSÉ Corporation, together with its subsidiaries, manufactures, markets, and sells cosmetics primarily in Asia, the United States, and internationally. It offers cleansing, facial wash, toner, emulsion, cream, gel/serum, pack mask, lip care, and massage products. The company also provides sunscreen, fragrance, makeup goods, hair products, beauty supplements, and other cosmetics. It offers its cosmetics under the DECORTÉ, JILLSTUART, ADDICTION, INFINITY, Awake, tarte, ALBION, MIYABI, Paul & Joe, IGNIS, Elegance, INFIORE, ANNA SUI, Predia, iMPREA, X-Barrier, ACNEO, ASTALUXE, MAIHADA, LECHÉRI, ESPRIQUE, SEKKISEI, ONE BY KOSÉ, Visée, FASIO, NAILHOLIC, BIOLISS, Magnifique, CLEAR TURN, BIOLISS, Je l'aime, softymo, SUNCUT, MAKE KEEP MIST, and GRACE ONE brands. It offers its products through specialty cosmetic stores, department stores, cosmetics stores, mass retailers, drugstores, convenience stores, and other retail outlets, as well as e-commerce. KOSÉ Corporation was founded in 1946 and is headquartered in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 300.41B | 289.14B | 299.98B | 279.39B | 327.72B | 333.00B | 303.40B | 266.76B | 243.39B | 207.82B | 190.05B | 170.69B | 166.51B | 171.07B | 172.56B | 178.12B | 180.22B | 176.39B | 177.81B | 169.91B |
| Cost of Revenue | 94.27B | 83.62B | 95.83B | 77.47B | 88.70B | 88.61B | 81.55B | 67.03B | 59.47B | 50.76B | 46.66B | 42.10B | 42.03B | 43.30B | 44.47B | 45.28B | 45.30B | 44.66B | 43.11B | 41.22B |
| Gross Profit | 206.13B | 205.52B | 204.15B | 201.92B | 239.02B | 244.39B | 221.85B | 199.74B | 183.92B | 157.06B | 143.39B | 128.59B | 124.48B | 127.77B | 128.10B | 132.84B | 134.92B | 131.73B | 134.70B | 128.69B |
| Gross Profit Ratio | 68.62% | 71.08% | 68.05% | 72.27% | 72.93% | 73.39% | 73.12% | 74.87% | 75.57% | 75.57% | 75.45% | 75.34% | 74.76% | 74.69% | 74.23% | 74.58% | 74.86% | 74.68% | 75.75% | 75.74% |
| Research & Development | 6.46B | 0.00 | 5.82B | 6.00B | 6.30B | 5.40B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 18.82B | 17.41B | 0.00 | 15.49B | 15.24B | 14.03B | 11.73B | 9.62B | 8.58B | 7.53B | 6.74B | 6.28B | 5.80B | 5.31B | 5.35B | 5.29B | 5.22B | 9.50B | 9.32B | 8.94B |
| Selling & Marketing | 74.04B | 69.93B | 0.00 | 80.53B | 86.92B | 84.91B | 75.38B | 69.89B | 63.94B | 55.11B | 49.57B | 44.80B | 42.01B | 42.12B | 44.15B | 46.39B | 47.18B | 46.34B | 46.21B | 43.88B |
| SG&A | 183.80B | 87.35B | 173.44B | 96.02B | 102.15B | 98.94B | 87.11B | 79.51B | 72.52B | 62.63B | 56.30B | 51.08B | 47.81B | 47.43B | 49.50B | 51.68B | 52.40B | 55.84B | 55.53B | 52.82B |
| Other Expenses | 397.00M | 96.04B | 338.67M | 4.08B | 572.00M | 443.00M | 86.33B | 81.06B | 232.00M | 343.00M | 228.00M | 170.00M | 450.00M | 320.00M | 550.00M | 315.00M | 259.00M | 198.00M | 345.00M | 252.00M |
| Operating Expenses | 189.86B | 183.39B | 178.91B | 188.63B | 198.79B | 191.97B | 173.44B | 160.57B | 149.28B | 134.41B | 124.45B | 116.72B | 93.45B | 93.86B | 96.80B | 98.27B | 100.86B | 104.28B | 101.43B | 96.92B |
| Cost & Expenses | 284.13B | 267.01B | 274.74B | 266.09B | 287.49B | 280.58B | 254.99B | 227.60B | 208.75B | 185.17B | 171.11B | 158.82B | 135.47B | 137.16B | 141.27B | 143.55B | 146.16B | 148.94B | 144.54B | 138.14B |
| Interest Income | 1.14B | 580.00M | 206.67M | 260.00M | 551.00M | 513.00M | 196.00M | 220.00M | 278.00M | 242.00M | 204.00M | 129.00M | 170.00M | 205.00M | 256.00M | 351.00M | 336.00M | 179.00M | 72.00M | 134.00M |
| Interest Expense | 11.00M | 60.00M | 16.00M | 17.00M | 7.00M | 2.00M | 5.00M | 7.00M | 14.00M | 8.00M | 35.00M | 40.00M | 42.00M | 49.00M | 56.00M | 82.00M | 77.00M | 65.00M | 45.00M | 111.00M |
| Depreciation & Amortization | 10.58B | 17.25B | 11.24B | 11.16B | 9.63B | 8.82B | 7.89B | 7.01B | 6.60B | 5.86B | 4.68B | 4.61B | 4.88B | 5.16B | 5.89B | 5.59B | 5.45B | 5.14B | 5.00B | 4.11B |
| EBITDA | 26.86B | 39.37B | 36.47B | 30.19B | 50.58B | 62.90B | 56.30B | 46.17B | 40.62B | 30.90B | 25.38B | 19.05B | 36.31B | 38.98B | 37.94B | 39.97B | 39.25B | 33.21B | 39.34B | 36.35B |
| EBITDA Ratio | 8.94% | 13.62% | 12.16% | 10.80% | 15.43% | 18.89% | 18.56% | 17.31% | 16.69% | 14.87% | 13.36% | 11.16% | 21.81% | 22.78% | 21.99% | 22.44% | 21.78% | 18.83% | 22.12% | 21.39% |
| Operating Income | 16.28B | 22.12B | 25.24B | 13.29B | 40.23B | 52.41B | 48.41B | 39.16B | 34.63B | 22.65B | 18.93B | 11.86B | 31.43B | 33.82B | 32.05B | 34.37B | 33.80B | 28.07B | 34.34B | 32.24B |
| Operating Income Ratio | 5.42% | 7.65% | 8.41% | 4.76% | 12.28% | 15.74% | 15.96% | 14.68% | 14.23% | 10.90% | 9.96% | 6.95% | 18.88% | 19.77% | 18.57% | 19.30% | 18.76% | 15.91% | 19.31% | 18.97% |
| Total Other Income/Expenses | 3.23B | 5.75B | 3.21B | 6.42B | 133.00M | 2.54B | -166.00M | 265.00M | -772.00M | 1.05B | 1.82B | 949.00M | -19.70B | -21.43B | -22.63B | -23.11B | -19.32B | -13.61B | -15.64B | -13.97B |
| Income Before Tax | 19.51B | 27.87B | 28.45B | 19.51B | 40.37B | 54.95B | 48.24B | 39.43B | 33.86B | 23.69B | 20.76B | 12.81B | 11.73B | 12.39B | 9.42B | 11.26B | 14.48B | 14.47B | 18.70B | 18.26B |
| Income Before Tax Ratio | 6.49% | 9.64% | 9.48% | 6.98% | 12.32% | 16.50% | 15.90% | 14.78% | 13.91% | 11.40% | 10.92% | 7.51% | 7.04% | 7.24% | 5.46% | 6.32% | 8.03% | 8.20% | 10.52% | 10.75% |
| Income Tax Expense | 6.97B | 8.40B | 10.18B | 7.67B | 12.53B | 15.95B | 14.72B | 15.49B | 13.26B | 10.45B | 8.85B | 5.81B | 6.18B | 5.16B | 3.79B | 5.69B | 6.55B | 6.74B | 8.62B | 8.35B |
| Net Income | 11.66B | 18.77B | 17.79B | 11.99B | 26.68B | 37.00B | 30.61B | 21.66B | 18.66B | 12.06B | 11.13B | 6.72B | 5.02B | 6.73B | 5.15B | 4.74B | 6.90B | 6.90B | 9.99B | 9.41B |
| Net Income Ratio | 3.88% | 6.49% | 5.93% | 4.29% | 8.14% | 11.11% | 10.09% | 8.12% | 7.66% | 5.80% | 5.86% | 3.94% | 3.02% | 3.93% | 2.99% | 2.66% | 3.83% | 3.91% | 5.62% | 5.54% |
| EPS | 204.41 | 329.03 | 311.83 | 210.11 | 467.76 | 648.70 | 536.63 | 379.66 | 327.04 | 211.37 | 195.15 | 117.22 | 86.51 | 115.87 | 88.81 | 81.55 | 115.50 | 114.22 | 180.00 | 186.51 |
| EPS Diluted | 204.41 | 329.03 | 311.83 | 210.11 | 467.76 | 648.70 | 536.63 | 379.66 | 327.04 | 211.37 | 195.15 | 117.22 | 86.51 | 115.87 | 88.81 | 81.55 | 115.50 | 114.22 | 180.00 | 186.51 |
| Weighted Avg Shares Out | 57.06M | 57.05M | 57.05M | 57.05M | 57.04M | 57.04M | 57.04M | 57.04M | 57.04M | 57.05M | 57.05M | 57.34M | 58.05M | 58.05M | 58.05M | 58.16M | 59.75M | 60.37M | 55.05M | 50.06M |
| Weighted Avg Shares Out (Dil) | 57.06M | 57.05M | 57.05M | 57.05M | 57.04M | 57.04M | 57.04M | 57.04M | 57.04M | 57.05M | 57.05M | 57.34M | 58.05M | 58.05M | 58.05M | 58.16M | 59.75M | 60.37M | 55.05M | 50.06M |
Source: https://incomestatements.info
Category: Stock Reports